Replies to post #96 on ChemoCentryx (CCXI)

[PAC]

Whats going on with CCXI? tanking premarket from highs

[Whalatane]

Crudeoil .. patients hate the steroids.

So CCX168 will either enable a lower dose of steroids when used in combination ...or used instead of steroids .

The CLASSIC trial will probably have data on rate of infection of steroids vs CCX168 also ......Infection related to steroid use is a major concern.

CCX168 appears to also show improvement in several indicators of renal disease . The caution tho is this is P 2 data . Co needs to get thru P 3 trials and then EU and FDA approval .....but so far it all looks good , especially to those at Vifor who have invested .
JMO
Kiwi